The Medical segment's accelerating growth (15.4%) and margin expansion (32.0% Adj. EBITDA) are the key positive, but the Manufacturing segment's swing to negative EBITDA and Software's revenue decline are headwinds. The €30M buyback authorization and strong cash position provide downside support. Monitor Q1 2026 results for Manufacturing stabilization and Medical momentum — the AGM on June 16 is a non-event.
Price Chart
Executive Summary
Materialise NV filed its annual management report and AGM notice for the June 16, 2026 meeting. FY2025 results show flat total revenue growth of 0.3% to €267.6M, with a strong 15.4% increase in the high-margin Medical segment offset by a 13.2% decline in Manufacturing and a 6.8% drop in Software. Net profit fell 42% to €7.7M from €13.4M, though Adjusted EBITDA grew 2.8% to €32.4M. The company completed its Euronext Brussels listing, authorized a €30M share buyback (€2.5M executed through April 2026), and fully remediated prior material weaknesses in internal controls. The RapidFit divestiture was immaterial.
Key Facts
- FY2025 revenue flat at €267.6M (+0.3% YoY); Medical segment grew 15.4% to €134.2M, Manufacturing fell 13.2% to €92.5M, Software fell 6.8% to €40.9M
- Net profit declined 42% to €7.7M from €13.4M; Adjusted EBITDA rose 2.8% to €32.4M
- Medical segment Adjusted EBITDA margin expanded to 32.0% from 30.6%; Manufacturing segment turned negative at -4.6% from +1.6%
- Cash and equivalents increased €31.6M to €133.9M; total debt rose €23.9M to €57.5M
- Material weaknesses in internal controls fully remediated during 2025
- Share buyback program authorized Nov 2025; 545,529 shares repurchased for €2.5M through April 2026
- RapidFit subsidiary divestiture completed at carrying value — no material gain/loss
- Board and management hold 73.4% of voting rights as of April 2026
Financial Impact
Revenue flat at €267.6M; net profit down 42% to €7.7M; Adjusted EBITDA up 2.8% to €32.4M; cash +€31.6M to €133.9M
Risk Factors
- Manufacturing segment continued weakness from macro headwinds and capacity reduction
- Software segment transition to cloud/subscription model may pressure near-term revenue
- Increased debt (€57.5M, up €23.9M) and net financial expense swing from +€4.7M to -€1.6M
- Foreign exchange volatility impacting reported results
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-062479 |
| Document: tm2614525d1_6k.htm | 0001104659-26-062479 |
| Document: tm2614525d1_ex99-1.htm | 0001104659-26-062479 |
| Document: 0001104659-26-062479-index-headers.html | 0001104659-26-062479 |
| Document: 0001104659-26-062479-index.html | 0001104659-26-062479 |
| Document: 0001104659-26-062479.txt | 0001104659-26-062479 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $8.65 | awaiting T+20 | — | $8.65 (−0.00%) |
Oct 19, 2026 6d ago | 6-K | $8.21 | awaiting T+20 | — | $8.65 (+5.36%) |
Oct 13, 2026 13d ago | 6-K | $8.13 | awaiting T+20 | — | $8.65 (+6.40%) |
Oct 5, 2026 21d ago | 6-K | $8.56 | awaiting T+20 | — | $8.65 (+1.05%) |
Sep 8, 2026 6w ago | 6-K | $7.46 $8.50 | ▲ +13.94% | ▲ +11.74% | $8.65 (+15.95%) |
Aug 28, 2026 8w ago | 6-K | $7.21 $8.75 | ▲ +21.36% | ▲ +21.73% | $8.65 (+19.97%) |
Jul 20, 2026 14w ago | 6-K | $6.60 $6.69 | ▲ +1.36% | ▼ −1.20% | $8.65 (+31.06%) |
Jul 13, 2026 15w ago | 6-K | $6.77 $6.87 | ▲ +1.48% | ▼ −1.01% | $8.65 (+27.77%) |
Jul 6, 2026 16w ago | 6-K | $7.04 $6.51 | ▼ −7.53% | ▼ −8.86% | $8.65 (+22.87%) |
Jun 29, 2026 17w ago | 6-K | $7.43 $6.44 | ▼ −13.32% | ▼ −12.30% | $8.65 (+16.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers